NFKB1 and diabetic kidney disease: Concurrently, NF-κB upregulates the transcription of IL-1β, IL-18, and TNF-α, creating a positive feedback loop that further amplifies its activity and promotes metabolic syndrome-related comorbidities such as diabetic nephropathy, foot ulcers and retinopathy [6].